Success Metrics

Clinical Success Rate
100.0%

Based on 8 completed trials

Completion Rate
100%(8/8)
Active Trials
4(29%)
Results Posted
25%(2 trials)

Phase Distribution

Ph not_applicable
6
43%
Ph phase_1
1
7%
Ph phase_4
1
7%
Ph phase_2
2
14%
Ph phase_3
1
7%

Phase Distribution

1

Early Stage

2

Mid Stage

2

Late Stage

Phase Distribution11 total trials
Phase 1Safety & dosage
1(9.1%)
Phase 2Efficacy & side effects
2(18.2%)
Phase 3Large-scale testing
1(9.1%)
Phase 4Post-market surveillance
1(9.1%)
N/ANon-phased studies
6(54.5%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

8 of 8 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

4

trials recruiting

Total Trials

14

all time

Status Distribution
Active(6)
Completed(8)

Detailed Status

Completed8
Recruiting4
Not yet recruiting2

Development Timeline

Analytics

Development Status

Total Trials
14
Active
4
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 11 (9.1%)
Phase 22 (18.2%)
Phase 31 (9.1%)
Phase 41 (9.1%)
N/A6 (54.5%)

Trials by Status

recruiting429%
not_yet_recruiting214%
completed857%

Recent Activity

Clinical Trials (14)

Showing 14 of 14 trials
NCT06880991

Development of Patient-Reported Outcome Measures Assessing Tumor Visibility and Appearance Concerns in Neurofibromatosis Type 1: A Qualitative Study

Recruiting
NCT06856226

Natural History Study to Determine Drug Metabolism Phenotype and Appropriate Germline Source DNA in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplant

Recruiting
NCT03011541Not Applicable

Stem Cell Ophthalmology Treatment Study II

Recruiting
NCT05556070Not Applicable

Brighter Bites & UT Physicians Produce Rx Program

Completed
NCT06640738Phase 4

Investigating the Optimal Remifentanil and Dexmedetomidine Concentration for Uterine Fibroid Ablation

Not Yet Recruiting
NCT06620796Phase 2

A Phase II Study of Ivonescimab Combined with Cadonilimab and Chemotherapy in Extensive-stage Small Cell Lung Cancer

Not Yet Recruiting
NCT04268641Not Applicable

Evaluation of Positioning Protocols on a Wheelchair in Hemiplegic Patients

Completed
NCT05517135

tReatment Individualisation By EBV stratificatiON in Nasopharyngeal Carcinoma: an Umbrella Platform Study (RIBBON-Umbrella)

Recruiting
NCT03084900Not Applicable

Patient-Centered Decision Support to Improve Diabetes Management in Pre-Teens and Adolescents With Type 1 Diabetes

Completed
NCT04804111Phase 2

Study of of URC102 to Assess the Efficacy and Safety in Gout Patients

Completed
NCT00742729Not Applicable

Increasing Colorectal Cancer Screening Among Filipino Americans

Completed
NCT00117806Not Applicable

Spinal Cord Injury Vocational Integration Program (SCI-VIP)

Completed
NCT01308541Phase 1

A Study to Characterize Pharmacokinetics (PK) and Pharmacodynamics (PD) of LUSEDRA® Administered as Continuous Infusion or Bolus Compared With Continuous Infusion of Propofol Injectable Emulsion

Completed
NCT00460265Phase 3

Study of Panitumumab Efficacy in Patients With Recurrent and/or Metastatic Head and Neck Cancer

Completed

All 14 trials loaded

Drug Details

Intervention Type
OTHER
Total Trials
14